Efficacy of Photobiomodulation in the Rehabilitation of Olfactory Dysfunctions Induced by Long COVID-19

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

On January 30, 2020, the WHO (World Health Organization) declared the new coronavirus pandemic as the sixth public health emergency of international concern. In February 2020, the virus was designated by the Coronavirus Study Group of the International Committee on Virus Taxonomy as severe acute respiratory syndrome coronavirus 2. Many reports have described the appearance of olfactory or gustatory dysfunction simultaneously with other pre-established symptoms of COVID-19. Symptoms such as loss of taste or smell may appear 2 to 14 days after being infected with COVID-19. Worldwide, evidence regarding anosmia (loss of smell) and dysgeusia (change in taste) has been associated with COVID-19 infection. OBJECTIVES: To evaluate the effectiveness of low-intensity laser in treating changes in smell and taste after COVID-19 infection and map which changes obtained the best results. MATERIAL AND METHODS: This is an intervention study whose sample will consist of 30 individuals with loss of smell and taste for more than 6 months after COVID-19 infection, aged 18 years or older.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: t
View:

• Patients who complained of loss of smell and taste more than 6 months after COVID-19 infection, aged 18 years or older, with proof of infection by PCR, will be included in the study.

Locations
Other Locations
Brazil
university hospital Gafree Guinle
RECRUITING
Rio De Janeiro
Contact Information
Primary
DEBORAH S SALES, phd
deborahsales.fono@gmail.com
+5521982161520
Time Frame
Start Date: 2022-06-05
Estimated Completion Date: 2024-12-22
Participants
Target number of participants: 30
Treatments
Experimental: low-intensity laser treatment group
This is an intervention study. The sample will consist of 30 individuals who will be allocated to the low-intensity laser treatment group.
Sponsors
Leads: Gaffree & Guinle Universitary Hospital
Collaborators: Rio de Janeiro State Research Supporting Foundation (FAPERJ)

This content was sourced from clinicaltrials.gov